Background It is unclear whether cardiovascular risk factor modification influences the
Methods In 1826 participants with newly diagnosed, screen-detected diabetes without albuminuria, we explored associations between risk of new albuminuria (≥2.5 mg mmol -1 for males and ≥3.5 mg mmol -1 for females) and (1) baseline cardio-metabolic risk factors and (2) changes from baseline to 1 year in systolic blood pressure (ΔSBP) and glycated haemoglobin (ΔHbA 1c ) using logistic regression. Conclusions Baseline measurements and changes in HbA 1c and SBP a year after diagnosis of diabetes through screening independently associate with new onset albuminuria 4 years later.
Results
Established multifactorial treatment for diabetes applies to cases identified through screening.
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People with type 2 diabetes are often exposed to a number of cardiovascular disease risk factors in addition to hyperglycaemia, with likely cumulative effects on complications frequency. 1,2 Diabetes case finding through screening theoretically enables identification of risk factors earlier in the disease trajectory, presenting an opportunity for aggressive multifactorial intervention, which is not possible until later following other methods of diagnosis. 3 Although a strategy combining optimised blood pressure, glucose, and lipids plus antiplatelet therapy has been shown to reduce the frequency of complications in patients with longstanding diabetes and microalbuminuria, 4 this has not been demonstrated in "screendetected" type 2 diabetes. 5, 6 Shorter duration of treatment exposure, coupled with a low initial risk of major complications limit attempts to quantify individual or cumulative effects of risk factor modification in this population. It is unknown whether long-term effects of initial intensive blood pressure and blood glucose control seen in patients with established diabetes will be similar in screendetected cases. 7, 8 Albuminuria is a biomarker of early chronic kidney disease, which independently predicts adverse renal and cardiovascular outcomes in both type 2 diabetes and essential hypertension, although albuminuria does not necessarily indicate the presence of early kidney disease. 9, 10 Its management in hypertensive patients with type 2 diabetes has been shown to be particularly effective if initiated early. 11 We aimed to quantify the association between baseline characteristics, treatment-associated changes in risk factors in the year-following diagnosis and development of albuminuria over 5 years in a cohort of people with screen-detected type 2 diabetes.
| MATERIALS AND METHODS

| ADDITION-Europe
The study design and rationale of the randomised controlled trial of multifactorial cardiovascular risk modification has been described elsewhere. 12 Briefly, Anglo-Danish- 
| Statistical analysis
Complete case analyses aimed to explore (1) Centre-specific and overall ORs were displayed using forest plots, and the proportion of variability between centres due to heterogeneity was computed as I 2 . Two-sided statistical tests were performed with 3 | RESULTS
| Study population
A total of 3057 patients were identified with screen-detected type 2 diabetes from 4 participating centres and entered the trial phase of the study. Participants with prevalent albuminuria at baseline (n = 547), or with missing data at baseline (n = 312) or follow-up (n = 372), were excluded, leaving a total of 1826 for this observational cohort analysis.
| Baseline and follow-up characteristics
At baseline, mean (SD) age was 59.9 (6.9) years, SBP147 (20) Twenty-one missing data (18 non-cases and 3 cases).
| DISCUSSION
Previous studies have shown that the risk of microvascular complications is significantly reduced by intensive blood glucose or blood pressure control in individuals with established type 2 diabetes, with no obvious threshold across blood pressure or glycated haemoglobin ranges. [16] [17] [18] [19] [20] As microvascular disease is linked to duration and initial control of hyperglycaemia, it follows that aggressively intervening earlier in the disease may be advantageous. 21 Albuminuria is an important independent risk factor for cardiovascular mortality in diabetes and its management has been shown to reduce the risk of progressive renal disease.
22,23
We have demonstrated that with the exception of dyslipidaemia, Odds ratios (OR) per unit increase of risk factors were estimated for each centre and then combined in a multivariate fixed-effect meta-analysis.
1% change HbA 1c = 10.9 mmol/mol. burden on the development of albuminuria, eg, presence of retinopathy and neuropathy, could not be ascertained as these were not quantified at baseline. Despite these caveats, we feel that this study improves our understanding of early onset type 2 diabetes and more importantly the likely effectiveness of widely adopted complication prevention strategies. To our knowledge, this is the largest cohort of screened cases of type 2 diabetes, with well-defined, repeated measurements allowing statistical approaches, which can infer independent associations with clinically important outcomes.
In conclusion, active smoking and BMI are independently associated with the development of albuminuria in patients with type 2 diabetes identified through screening. Subsequent improvement in blood pressure control a year after diagnosis in these patients is independently associated with lower risk of new onset albuminuria 4 years later. 
